aTyr Pharma (ATYR) Stock Statistics & Valuation Metrics

aTyr Pharma has a market cap or net worth of $57.04M. The enterprise value is $47.08M.

aTyr Pharma has 98,051,210 shares outstanding. The number of shares has decreased by -2.65% in one year.

aTyr Pharma’s return on equity (ROE) is -1.10 and return on invested capital (ROIC) is -96.45%.

The current PE Ratio of aTyr Pharma is ―. aTyr Pharma’s PEG ratio is 0.14.

In the last 12 months, aTyr Pharma had revenue of 190.00K and earned -74.12M in profits. Earnings per share was -0.80.

In the last 12 months, operating cash flow was -59.08M and capital expenditures -215.00K, giving a free cash flow of -59.30M billion.

aTyr Pharma pays an annual dividend of ―, resulting in a dividend yield of ―

aTyr Pharma upcoming earnings date is Aug 12, 2026, After Close (Confirmed).

aTyr Pharma as a current ratio of 5.30, with Debt / Equity ratio of 20.20%

In the past 12 months, aTyr Pharma has paid 0.00 in taxes.

aTyr Pharma EV to EBITDA ratio is -1.02, with an EV/FCF ratio of -1.19.

aTyr Pharma has $66.51M in cash and marketable securities with $11.70M in debt, giving a net cash position of $54.81M billion.

Gross margin is -11754.74%, with operating margin of -40856.32%, and net profit margin of -39009.47%.

The average price target for aTyr Pharma is $3.13, which is 11.43% higher than the current price. The consensus rating is Moderate Buy